Inhibrx Biosciences, Inc. (INBX) cash on hand

Cash · fiscal 2025
$124.22M

Inhibrx Biosciences, Inc. (INBX) held cash of $124.22M at the end of fiscal 2025 (December 31, 2025). That is 18.6% lower than the $152.60M of fiscal 2024. Figures as of 18 Nov 2026, 07:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$124.22M
Change on fiscal 2024
−18.6%
Highest on record
$277.92Mfiscal 2023
Lowest on record
$124.22Mfiscal 2025
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Inhibrx Biosciences, Inc. cash on hand, in more detail

Across the 3 fiscal years on record (2023–2025), the highest was $277.92M in fiscal 2023 and the lowest $124.22M in fiscal 2025.

History · 3 fiscal years

Cash by fiscal year

Inhibrx Biosciences, Inc. cash on hand, year by year

Inhibrx Biosciences, Inc. (INBX) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$124.22M 18.6% down
2024$152.60M 45.1% down
2023$277.92M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on INBX

Inhibrx Biosciences, Inc., figure by figure

Inhibrx Biosciences, Inc. (INBX) overview: price, valuation and scorecard

Inhibrx Biosciences, Inc. cash on hand: questions and answers

How much cash does Inhibrx Biosciences, Inc. have?

Inhibrx Biosciences, Inc. (INBX) held cash of $124.22M at the end of fiscal 2025 (December 31, 2025). That is 18.6% lower than the $152.60M of fiscal 2024.

What are the highest and lowest cash figures on record for Inhibrx Biosciences, Inc.?

Across the 3 fiscal years on record (2023–2025), the highest was $277.92M in fiscal 2023 and the lowest $124.22M in fiscal 2025.

How is Inhibrx Biosciences, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Inhibrx Biosciences, Inc. (INBX) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/INBX/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.